Case Study

Science 37 Launches Infectious Disease Prevention Study in Just 12 Weeks

A biotech sponsor contracted Science 37 to help enroll patients in a global Phase 2/3…

Case Study

Science 37 Accelerates Oncology Clinical Trial Timeline by 3 Years

A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the…

Scientific Poster

Preliminary Results from an Interventional Decentralized Clinical Trial

A top pharma company partnered with Science 37 to conduct the first-ever interventional decentralized clinical…

Case Study

The Direct-to-Patient Site in Action: A Case Study Collection

The Science 37 Direct-to-Patient Site is a virtual site that expands patient access to clinical trials…

Case Study

The Science 37 Direct-to-Patient Site in Action: A Fully Decentralized Trial for a Rare Vascular Disorder

A biopharma company was planning a Phase III, randomized, double-blind, placebo-controlled clinical trial for a…

Case Study

The Science 37 Direct-to-Patient Site in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial

A biopharma company was conducting a Phase II randomized controlled clinical trial in the United…

Case Study

Decentralized in Action: How Science 37 Accelerated Enrollment for a Diagnostic Oncology Trial

A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the…

Case Study

The Science 37 Direct-to-Patient Site in Action: Accelerating Enrollment for an Infectious Disease Trial

A biopharma company was conducting a phase II randomized controlled trial for an infectious disease.…

Case Study

Science 37 Uses the Direct-to-Patient Site to Support Clinical Trial in Rare Neurodegenerative Disease

An industry leading pharmaceutical company implemented the Science 37’s Direct-to-Patient Site to reduce patient patient…

Case Study

Science 37 Utilizes Flexibility of the Direct-to-Patient Site Model in Study of Rare Disease

A biotech company approached Science 37 to develop a virtualized process to evaluate patients who may…

Case Study

Science 37 Direct-to-Patient Site Delivers Broad Patient Access in MDD Trial

A global leader in pharmaceuticals was looking to pilot an interventional study in major depressive…

Scientific Poster

Evidence From Two Parallel Depression Trials

The adoption of the Decentralized Clinical Trial model in psychiatry has been tempered by concern…